SCHEMBL733458

SCHEMBL733458

COC(=O)c1cc(OCc2ccccc2)nc(-c2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.58
LMNA P02545 1/20 0.58
LTB4R Q15722 8/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
KDM5B Q9UGL1 1/20 0.46
MCL1 Q07820 1/20 0.45
GLA P06280 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
NUDT1 P36639 1/20 0.43
GAA P10253 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PPIA P62937 1/20 0.43
TACR3 P29371 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21551106 0.89 LMNA (0.52) HPGDLMNALTB4RALDH1A1KDM4E
SCHEMBL30931797 0.89 LMNA (0.52) HPGDLMNALTB4RALDH1A1KDM4E
SCHEMBL8987083 0.84 LTB4R (0.55) LTB4RGABRG2GABRB3GABRA5GABRA3
SCHEMBL28493223 0.84 ALDH1A1 (0.70) HPGDLTB4RALDH1A1KDM4EGLA
SCHEMBL763288 0.84 LTB4R (0.56) LTB4RALDH1A1KDM4E
SCHEMBL30931811 0.83 LMNA (0.59) HPGDLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL730969 0.83 LMNA (0.59) HPGDLMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL28490522 0.82 TSHR (0.57) HPGDALDH1A1KDM4EGLASMN1; SMN2
SCHEMBL6728049 0.79 MEN1 (0.48) HPGDLMNALTB4RALDH1A1KDM4E
SCHEMBL5550995 0.79 HPGD (0.59) HPGDLMNAKDM4EKDM5BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112048734-B Regioselective electrochemical synthesis method of nitrogen-containing aromatic heterocyclic carboxylic ester 四川大学 2022-06-10 CN disclosed
CN-112048734-A Regioselective electrochemical synthesis method of nitrogen-containing aromatic heterocyclic carboxylic acid 四川大学 2020-12-08 CN disclosed
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 HPGD 2417/4885LMNA 2503/4885LTB4R 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.